Showing results (21-30 of 160) with videos related to
Sort By:
Pageof 16
Arteriosclerosis, Thrombosis, and Vascular Biology|October 6, 2007
Intrinsic pathway of coagulation and arterial thrombosisDavid Gailani, Thomas RennéPlos One|April 6, 2016
Factor XI Deficiency Alters the Cytokine Response and Activation of Contact Proteases during Polymicrobial Sepsis in MiceCharles E Bane, Ivan Ivanov, Anton Matafonov, et al.Research and Practice in Thrombosis and Haemostasis|June 17, 2020
The contact activation system as a potential therapeutic target in patients with COVID-19Joseph J Shatzel, Emma P DeLoughery, Christina U Lorentz, et al.Hematology/Oncology Clinics of North America|September 18, 2016
The Intrinsic Pathway of Coagulation as a Target for Antithrombotic TherapyAllison P Wheeler, David GailaniExpert Review of Hematology|August 29, 2009
Update on the physiology and pathology of factor IX activation by factor XIaStephen B Smith, David GailaniArteriosclerosis, Thrombosis, and Vascular Biology|April 6, 2013
Antithrombotic effect of antisense factor XI oligonucleotide treatment in primatesJeffrey R Crosby, Ulla Marzec, Alexey S Revenko, et al.Expert Review of Hematology|May 25, 2016
Why factor XI deficiency is a clinical concernAllison P Wheeler, David GailaniDrug Discovery Today|June 3, 2014
Factor XI as a target for antithrombotic therapyCharles E Bane, David GailaniClinics in Laboratory Medicine|May 15, 2026
Pharmacologic Factor XI/XIa Inhibitors: What the Laboratory Hematologist Needs to KnowJeffrey I Weitz, David GailaniCurrent Opinion in Hematology|July 7, 2011
Factor XI and XII as antithrombotic targetsFelicitas Müller, David Gailani, Thomas RennéPageof 16